Medication treatment strategies in the MTA study: Relevance to clinicians and researchers

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 35, Issue 10, 1996, Pages 1304-1313

  Greenhill, Laurence L ^a,k   Abikoff, Howard B ^c   Arnold, L Eugene ^b   Cantwell, Dennis P ^d   Conners, C Keith ^e   Elliott, Glen ^f   Hechtman, Lily ^g   Hinshaw, Stephen P ^f   Hoza, Betsy ^h   Jensen, Peter S ^b   March, John S ^e   Newcorn, Jeffrey ⁱ   Pelham, William E ^j   Severe, Joanne B ^b   Swanson, James M ^d   Vitiello, Ben ^b   Wells, Karen ^e  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DUKE UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g MCGILL UNIVERSITY   (Canada)

^h PURDUE UNIVERSITY   (United States)

ⁱ Mt Sinai Medical Center   (United States)

^j UNIVERSITY OF PITTSBURGH   (United States)

^k NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

more..

Author keywords

attention deficit hyperactivity disorder; dextroamphetamine; imipramine; methylphenidate; multisite trial; pemoline

Indexed keywords

DEXAMPHETAMINE; METHYLPHENIDATE;

CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION THEORY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MINIMAL BRAIN DYSFUNCTION; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

EID: 10144220645     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199610000-00017     Document Type: Article

References (47)

1. Abikoff H (1991), Interaction of methylphenidate and multimodal therapy in the treatment of attention-deficit hyperactivity disorder. In: Ritalin: Theory and Patient Management, Greenhill L, Osman B, eds. New York: Maty Ann Liebert, pp 147-154
2. Arnold L, Christopher J, Huestis R, Smeltzer D (1978), Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction. Arch Gen Psychiatry 35:463-473
3. Barkley R (1988), Child behavior rating scales and checklists. In: Assessment and Diagnosis in Child Psychopathology, Rutter M, Tuma A, Lann I, eds. New York: Guilford, pp 113-155
4. Barkley R, Anastopoulos A, Goevremont D, Fletcher K (1991), Adolescents with ADHD: patterns of behavioral adjustment, academic functioning, and treatment utilization. J Am Acad Child Adolesc Psychiatry 30:752-761
5. Barkley R, DuPaul G, Costello A (1993), Stimulants. In: Practitioner's Guide to Psychoactive Drugs for Children and Adolescents, Werry J, Aman M, eds. New York: Plenum, pp 224-229
6. Barkley R, Fisher M, Newby R, Breen M (1988), Development of a multimethod clinical protocol for assessing stimulant drug response in ADD children. J Clin Child Psychol 17:14-24
7. Barlow D (1981a), On the relation of clinical research to clinical practice: current issues, new directions. J Consult Clin Psychol 49:147-155
8. Barlow D (1981b), A role for clinicians in the research process. Behav Assess 3:227-233
9. Birmaher B, Greenhill L, Cooper T, Fried J, Maminski B (1989), Sustained release methylphenidate: pharmacokinetic studies in ADDH males. J Am Acad Child Adolesc Psychiatry 28:768-772
10. Buitelaar J, Gaag R, Swaab-Barneveld H, Kuiper M (1995), Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34:1025-1033
11. Burke J, Pincus H, Pardes H (1986), The clinician-researcher in psychiatry. Am J Psychiatry 143:968-975
12. Cohen L, Sergeant M, Sechrest L (1986), Use of psychotherapy research by professional psychologists. Am Psychol 41:198-206
13. DHHS, PHS, ADAMHA, NIMH (1992), Request for Applications: Cooperative Agreement for a Multi-Site Multimodal Treatment Study of Attention-Deficit Hyperactivity Disorder (ADHD)/Attention-Deficit Disorder (ADD). MH-92-03 (Catalog of Federal Domestic Assistance 93.2452). Rockville, MD: National Institute of Mental Health
14. Dulcan M (1990), Using psychostimulants to treat behavioral disorders of children and adolescents. J Child Adolesc Psychopharmacol 1:7-20
15. DuPaul G, Barkley R (1990), Medication therapy. In: Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment, 2nd ed. New York: Guilford, pp 573-612
16. Elia J, Borcherding B, Rapoport J, Keysor C (1991), Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true non-responders? Psychiatry Res 36:141-155
17. Greenhill L (1995), Attention-deficit hyperactivity disorder: the stimulants. Child Adolesc Psychiatr Clin North Am 4:123-168
18. Hinshaw S (1994), Attention Deficits and Hyperactivity in Children. Thousand Oaks, CA: Sage, p 106
19. Hoshmand L, Polkinghorne D (1992), Redefining the science-practice relationship and professional training. Am Psychol 47:55-66
20. Jacobvitz D, Srouge L, Stewart M, Leffert N (1991), Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: a comprehensive review. J Am Acad Child Adolesc Psychiatry 29:677-688
21. Klein R, Wender P (1995), The role of methylphenidate in psychiatry. Arch Gen Psychiatry 52:429-433
22. Kutcher S (1986), Assessing and treating attention deficit disorder in adolescents: the clinical application of a single-case research design. Br J Psychiatry 149:710-715
23. Loney J, Milich R (1982), Hyperactivity, inattention, and aggression in clinical practice. In: Advances in Developmental and Behavioral Pediatrics, vol 3, Gadow K, Bialer I, eds. Greenwich, CT: JAI Press
24. Mathieu M (1990), New Drug Development: A Regulatory Overview. Cambridge, MA: Parexel International Corporation
25. Morrow-Bradley C, Elliott R (1986), Utilization of psychotherapy research by practicing psychotherapists. Am Psychol 41:188-197
26. Pardes H (1986), Neuroscience and psychiatry: marriage or coexistence? Am J Psychiatry 143:1205-1212
27. Pelham W (1982), Hyperactivity: diagnosis, etiology, nature, and treatment. In: Handbook of Psychology and Health I, Gatchel N, Baum A, Singer J, eds. Hillsdale, NJ: Erlbaum
28. Pelham W (1993), Pharmacotherapy for children with attention deficit hyperactivity disorder. Sch Psychol Rev 22:199-227
29. Pelham W, Greenslade K, Vodde-Hamilton M et al. (1990), Relative efficacy of long-acting stimulants on children with attention-deficit hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline. Pediatrics 86:226-237
30. Pelham W, Hoza B (1987), Behavioral assessment of psychostimulant effects on ADD children in a summer day treatment program. In: Advances in Behavioral Assessment of Children and Families, 3rd ed, Prinz R, ed. Greenwich, CT: JAI Press, pp 3-33
31. Pelham W, Milich R (1991), Individual differences in response to Ritalin in classwork and social behavior. In: Ritalin: Theory and Patient Management, Greenhill L, Osman B, eds. New York: Mary Ann Liebert, pp 203-221
32. Pelham W, Milich R, Murphy D, Murphy H (1989), Normative data on the IOWA Conners Teacher Rating Scale. J Clin Child Psychol 3:259-262
33. Rapport M, DuPaul G, Kelly K (1989), Attention deficit hyperactivity disorder and methylphenidate: the relationship between gross body weight and drug response in children. Psychopharmacol Bull 25:285-290
34. Richters JE, Arnold E, Jensen PS et al. (1995), NIMH Collaborative Multisite Multimodal Treatment Study of Children with ADHD: 1. Background and Rationale. J Am Acad Child Adolesc Psychiatry 34:987-1000
35. Riddle M (1994), Institute I-VI: clinical management in child and adolescent psychopharmacology. In: Scientific Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New York, p 3
36. Safer D (1994), The impact of eight law suits on methylphenidate sales. In: Scientific Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, p 46
37. Safer D, Krager J (1988), A survey of medication treatment for hyperactive/ inattentive students. JAMA 260:2256-2258
38. Satterfield J, Satterfield B, Cantwell D (1981), Three-year multimodality treatment study of 100 hyperactive boys. J Pediatr 98:650-655
39. Sprague R (1978), Principals of clinical trials and social, ethical and legal issues of drug use in children. In: Pediatric Psychopharmacology: The Use of Behavior Modifying Drugs in Children, Werry J, ed. New York: Brunner/Mazel, pp 109-135
40. Sprague R, Sleator E (1977), Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behavior. Science 198:1274-1276
41. Swanson J (1990), School-Based Assessment Inventories for ADD Students. Miami: KC Publishing
42. Swanson J, Roberts W, Zucker K (1978), Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics 61:21-29
43. Vyborova L, Nahunek K, Drtilkova I, Balastikova B, Misurec J (1984), Intraindividual comparison of 21-day application of amphetamine and methylphenidate in hyperkinetic children. Act Nerv Super (Praha) 26:268-269
44. Weisz J, Donenberg G, Han S, Weiss B (1995), Bridging the gap between lab and clinic in child and adolescent psychotherapy. J Consult Clin Psychol 63:688-701
45. Wilens T, Biederman J (1992), The stimulants. Psychiatr Clin North Am 15:191-222
46. Winsberg B, Press M, Bialer I, Kupietz S (1974), Dextroamphetamine and methylphenidate in the treatment of hyperactive/aggressive children. Pediatrics 53:236-241
47. Zametkin A, Rapoport J (1987), Neurobiology of attention-deficit disorder with hyperactivity: where have we come in 50 years? J Am Acad Child Adolesc Psychiatry 26:676-686